about
sameAs
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.Chair's summary: Innate and adaptive immune responses in airway diseaseLung macrophages contribute to house dust mite driven airway remodeling via HIF-1αNeurotactin, a membrane-anchored chemokine upregulated in brain inflammationOsteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsetsRANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosisDevelopments in the field of allergy in 2009 through the eyes of Clinical and Experimental AllergyMatrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease.Pulmonary ORMDL3 is critical for induction of Alternaria-induced allergic airways disease.Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions.Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function.Chronic inflammation and asthma.Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cellsAlternaria-derived serine protease activity drives IL-33-mediated asthma exacerbationsIL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma.Chemokines in allergic lung inflammation.γδT cells regulate chronic airway inflammation and development of airway remodelling.Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challengeVitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways diseaseLung microbiota promotes tolerance to allergens in neonates via PD-L1.Chemokines in allergic airway disease.Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthmaSpecial delivery: how macrophages get the message acrossPerinatal paracetamol exposure in mice does not affect the development of allergic airways disease in early lifePediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice.IL-33 family members and asthma - bridging innate and adaptive immune responses.CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses.The Th17 pathway in cystic fibrosis lung disease.Orchestrating house dust mite-associated allergy in the lung.Eosinophils in the pathogenesis of allergic airways disease.Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationAllergen-induced airway remodellingRegulatory T cells in asthma.CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling.Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapy
P50
Q25255561-1B1751FD-4D5B-4759-9D8D-10FB4A351C68Q26860690-83FF3E3F-0B56-4F8D-942E-F7A00B227089Q27311214-D8A611E4-2706-4595-9927-4AFDBE47BC73Q28240071-E4ADA5DB-9538-4054-B716-44DAC2D3C9E7Q28298064-C0F1C0A8-6BCD-4163-9687-1EAA49144229Q28307643-1C0E66B9-6263-496B-813B-E0E12FFC986AQ28385685-568AFEA4-BEE8-4D7D-B954-3166D43CA216Q30370370-D2A2968B-6581-4A50-BD4A-33A8B6C567A0Q30573092-8B38936E-2714-4568-ABA7-0D2FA16035ABQ33468762-2B38F5EF-4FE4-4893-8D94-2106BB4471F2Q33634444-B3FD7556-32F0-4118-A2D8-54B4D2B56BCEQ33756004-2BFF9480-F037-4C32-90A0-243C004BC3FDQ33758275-BDE7EE48-0BC3-41E3-9DBB-1FA33154A35DQ34073570-3CDD7333-E154-4A63-9B86-5B853082439CQ34118502-F1919F02-0F47-4090-9927-A7AD5BAC29BAQ34121201-8AAE9AE0-9862-45CA-9F65-C70F3DC8A355Q34446514-314C267D-3C69-40C0-A682-4E82B6FF7256Q34548329-CA789C48-7B1D-4F10-9C56-1D55E22AFE1BQ34548841-99ECC475-9C32-4DAD-958B-38E6DF5989BBQ34819452-693B6052-8AF9-4A0C-A27F-7592EBB76102Q35086209-61124CC8-C2C0-4774-9092-9594C1F146EAQ35165937-D6E9771C-D550-4102-AC4F-CCA1D59222E1Q35193668-EC83B239-61E0-4AB8-A43C-42DD1161163BQ35275345-E35C2BE8-E99F-494F-A197-CBA0F80D6001Q35568450-9923CFEB-949D-440C-9660-37A05CC09BF7Q35678019-360A7802-788B-4C21-9DD2-5864105AC36AQ35947796-813BB248-3ACE-4891-93B8-FAF9D41E8CC0Q36023560-6EC84B4A-3361-401C-AF2A-E8162DD99507Q36050542-00261899-F702-4DFA-8D15-9EA81F33F5ECQ36050546-A2EF4972-6658-45C1-BF51-AC8912A7FF8DQ36050578-AC51F5F3-4F5D-445A-9B5D-60752E97A4C3Q36054539-DE6B7EAE-1BAF-47E8-8045-6B4DC4511F26Q36054545-FD73CDFE-D023-483B-9EF0-C7F585A9E93FQ36059786-037FE11F-FC17-464A-84AF-A9D2F5FBCEDEQ36062727-2F2A20E8-D643-4CD2-904C-8FCC8AC13F43Q36062733-119D4206-FF61-47DB-B9CC-329468DC12E3Q36064548-D9EE33D2-E214-4BA1-9C84-3353F6F9042CQ36064553-943D02CA-322C-4AB5-BFE0-2BABF21CF1EDQ36064557-A44F00A7-ED84-424E-9797-58CDC16087B6Q36064562-4A5CCBA1-9418-4903-9D19-10E1F5B20903
P50
description
scientist
@en
wetenschapper
@nl
name
Clare M Lloyd
@nl
Clare M. Lloyd
@en
Clare M. Lloyd
@es
type
label
Clare M Lloyd
@nl
Clare M. Lloyd
@en
Clare M. Lloyd
@es
altLabel
Clare Lloyd
@en
Clare M. Lloyd
@en
Clare Margaret Lloyd
@en
prefLabel
Clare M Lloyd
@nl
Clare M. Lloyd
@en
Clare M. Lloyd
@es
P214
P244
P101
P106
P1960
HDhlu7AAAAAJ
P21
P214
P244
n2012184457
P31
P496
0000-0001-8977-6726
P734
P7859
lccn-n2012184457